Hypersensitivity to Excipients in Drugs: An EAACI Position Paper
Authors:
- Lene H. GarveyLGLene H. Garvey
- Knut BrockowKBKnut Brockow
- Annick BarbaudABAnnick Barbaud
- Charlotte G. MortzCMCharlotte G. Mortz
- Gianfranco CalogiuriGCGianfranco Calogiuri
- Asli GelincikAGAsli Gelincik
- Osman O. YeğitOYOsman O. Yeğit
- Alla NakonechnaANAlla Nakonechna
- Rik SchrijversRSRik Schrijvers
- Toon IevenTIToon Ieven
Open Access
Abstract
Drugs contain active pharmaceutical ingredients and excipients, compounds which enhance the pharmacokinetics, stability and palatability of the pharmaceutical formulation. While most drug hypersensitivity reactions (DHR) are caused by active ingredients, excipients may also be involved. Excipient‐related DHR are easily overlooked and may lead to repeated anaphylaxis in patients exposed to pharmaceutical formulations containing different active ingredients. We performed an extensive review of the literature to provide practical recommendations on when to suspect and how to diagnose and manage excipient hypersensitivity. Where literature was limited, the collective experience of the authors was taken into consideration. Excipient hypersensitivity should be suspected in patients with a history of anaphylaxis to multiple drugs with chemically unrelated active ingredients and specific drug classes such as oral laxatives and injectable depot steroids or progestogens. Polyethylene glycol, methylcelluloses, gelatine, povidone and mannitol were identified as the most common culprits of DHR. DHR evaluation should include review of the product monograph to ascertain the presence of possible culprit excipients. Specific diagnostic tests for excipients should be performed when appropriate, including skin, in vitro and provocation testing with pure excipients and drugs with and without the excipient as controls. We provide consensus‐based excipient‐specific recommendations on diagnostic testing based on best available evidence.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (1805523N)
- European Academy of Allergy and Clinical Immunology
This publication has 122 references indexed in Scilit:
- A systematic review of isotretinoin and its contraindications in peanut, soybean and cashew nut allergiesJEADV Clinical Practice, 2024
- Fractionated vaccination with mRNA COVID‐19 vaccine is safe for patients with polyethylene glycol allergyClinical and Translational Allergy, 2023
- Allergy to polyethylene glycol and polysorbates in a patient cohort: Diagnostic work‐up and decision points for vaccination during the COVID‐19 pandemicClinical and Translational Allergy, 2022
- Incidence of Cutaneous Reactions After Messenger RNA COVID-19 VaccinesJAMA Dermatology, 2021
- Comparison of hypersensitivity rates to intravenous and intramuscular PEG‐asparaginase in children with acute lymphoblastic leukemia: A meta‐analysis and systematic reviewPediatric Blood & Cancer, 2016
- Ethylenediamine, profile of a sensitizing excipientInternational Journal of Clinical Pharmacy, 1985
- Allergic Dermatitis to Benzyl Alcohol in an Injectable SolutionArchives of Dermatology, 1984
- Paraben AllergyJAMA, 1977
- Local anesthetic sensitivity: Report of a caseOral Surgery, Oral Medicine, Oral Pathology, 1969
- Anaphylactic Reaction to MannitolArchives of Ophthalmology (1950), 1967